Related Experiment Video
Updated: Aug 26, 2025
10:48
PET and MRI Guided Irradiation of a Glioblastoma Rat Model Using a Micro-irradiator
Published on: December 28, 2017
9.6K
A rational approach to the CNS tumors diagnostics
Ceskoslovenska Patologie
|October 12, 2022
Summary
The latest WHO classification for CNS tumors relies heavily on molecular diagnostics. This study outlines a practical approach using molecular methods like RT-PCR, Sanger sequencing, MLPA, NGS, and methylation arrays for accurate tumor diagnosis.
Area of Science:
- Neurology
- Oncology
- Molecular Diagnostics
Background:
- The World Health Organization (WHO) classification of Central Nervous System (CNS) tumors has shifted towards molecular diagnostics.
- Accurate diagnosis of certain CNS tumor entities is impossible without employing molecular techniques.
Purpose of the Study:
- To present a rational and systematic diagnostic workflow for CNS tumors.
- To integrate conventional and advanced molecular methods for improved diagnostic accuracy.
Main Methods:
- Utilized conventional molecular techniques including Reverse Transcription Polymerase Chain Reaction (RT-PCR), Sanger sequencing, and Multiplex Ligation-dependent Probe Amplification (MLPA).
- Incorporated Next-Generation Sequencing (NGS) and methylation Single Nucleotide Polymorphism (SNP) array analysis for comprehensive molecular profiling.
Main Results:
- Demonstrated the feasibility of a diagnostic strategy combining standard and next-generation molecular assays.
- Showcased how these methods enable the precise classification of CNS tumors according to the new WHO guidelines.
Conclusions:
- A structured diagnostic approach integrating diverse molecular methods is essential for modern CNS tumor classification.
- This strategy ensures that even rare or complex CNS tumor entities can be accurately identified, aligning with the latest WHO standards.
